Jonathan Anderman serves as General Counsel at Compass Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan Anderman has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 720,000 shares valued at $0.
Jonathan Anderman currently holds 720,000 shares of Compass Therapeutics, Inc. (CMPX), valued at approximately $0. This represents their equity stake as General Counsel.
Based on SEC Form 4 filings, Jonathan Anderman has been a net neutral trader of CMPX stock. They have purchased $0 and sold $0 worth of shares.
Jonathan Anderman's most recent insider trade was on Jan 2, 2026, when they sold 720,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.17 |
| Discretionary |